samedan logo
 
 
spacer
home > white papers > Accelerating the Time from DNA to Material - Merck
WHITE PAPERS
logo_Merck.jpg

Merck

phone +33 (0)5 57 960 960
email IECustomerrelations@merckgroup.com
web http://www.merckmillipore.com/GB/en
email 1 rue Jacques Monod, Site Montesquieu, 33650 Martillac, France

Accelerating the Time from DNA to Material

Cell line development is a critical step in upstream process development for monoclonal antibodies (mAbs). Unfortunately, the search for the bestproducing clone can be labor- and resource-intensive and is often compared with looking for a needle in a haystack. Cells must first be engineered to produce the biologic of interest and the cell line generated from a high producing clone must deliver a sufficiently high titer to support clinical studies, and ultimately commercialization of the therapeutic.
Accelerating the Time from DNA to Material
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Advanced Clinical Continues Global Expansion Into Asia-Pacific With New Office in Australia

Advanced Clinical, a global clinical research services organization, continues to build upon its growth strategy in the Asia-Pacific (APAC) region with the opening of a new office in Sydney, Australia.
More info >>


White Papers


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement